azacitidine has been researched along with Syndrome in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Attarian, S; Delmont, E; Escoda, T; Farnault, L; Gallard, J; Marceau-Renaut, A | 1 |
| Laufer, CB; Roberts, O | 1 |
| Badens, C; Charpentier, A; Fournier, M; Herbaux, C; Nibourel, O; Pissard, S; Preudhomme, C; Renneville, A; Rose, C | 1 |
| Berger, EG; Rusconi, S; Thurnher, M | 1 |
| Berger, EG | 1 |
| Kumar, A | 1 |
| Kraakman, ME; Lambert, M; Schuurman, RK; van den Elsen, PJ; van Eggermond, MC | 1 |
| Bílá, V; Kren, V | 1 |
1 review(s) available for azacitidine and Syndrome
| Article | Year |
|---|---|
Tn-syndrome.
Topics: Anemia, Hemolytic; Antibodies, Monoclonal; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Azacitidine; Blood Cells; Erythrocyte Membrane; Galactosyltransferases; Hematologic Diseases; Humans; Lectins; Leukopenia; Molecular Structure; Syndrome; Thrombocytopenia | 1999 |
7 other study(ies) available for azacitidine and Syndrome
| Article | Year |
|---|---|
Azacitidine, a therapeutic option in Lewis and Sumner syndrome associated with VEXAS syndrome.
Topics: Azacitidine; Humans; Neural Conduction; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Syndrome | 2022 |
Differentiation syndrome in acute myeloid leukemia after treatment with azacitidine.
Topics: Aged; Azacitidine; Female; Fever; Humans; Hypotension; Leukemia, Myeloid, Acute; Pericardial Effusion; Syndrome | 2015 |
Acquired alpha thalassemia myelodyslastic/myeloproliferative syndrome (ATMDS): evolution on hypomethylating agent therapy.
Topics: Aged; alpha-Thalassemia; Antimetabolites, Antineoplastic; Azacitidine; DNA Methylation; Evolution, Molecular; Fatal Outcome; Humans; Leukemia, Myelomonocytic, Chronic; Male; Syndrome | 2011 |
Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome.
Topics: Alleles; Antigens, Tumor-Associated, Carbohydrate; Azacitidine; Butyrates; Butyric Acid; Carbohydrate Sequence; Clone Cells; Enzyme Repression; Galactosyltransferases; Hematologic Diseases; Humans; Kinetics; Molecular Sequence Data; Syndrome; T-Lymphocytes; Tumor Cells, Cultured | 1993 |
Rett and ICF syndromes: methylation moves into medicine.
Topics: Abnormalities, Multiple; Animals; Azacitidine; Chromosomal Proteins, Non-Histone; Craniofacial Abnormalities; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; DNA Methyltransferase 3B; DNA Mutational Analysis; DNA-Binding Proteins; Embryonic and Fetal Development; Female; Gene Expression Regulation, Developmental; Gene Silencing; Genes, Lethal; Genotype; Heterochromatin; Humans; Immunologic Deficiency Syndromes; Infant, Newborn; Male; Methyl-CpG-Binding Protein 2; Mice; Mutation, Missense; Phenotype; Repressor Proteins; Rett Syndrome; Sequence Deletion; Syndrome; X Chromosome | 2000 |
The MHC class II deficiency syndrome: heterogeneity at the level of the response to 5-azadeoxycytidine.
Topics: Azacitidine; Cell Line, Transformed; Decitabine; DNA; Gene Expression Regulation; Genes, MHC Class II; HLA-D Antigens; Humans; Immunologic Deficiency Syndromes; Lymphocytes; Methylation; Promoter Regions, Genetic; Syndrome; Transcription, Genetic | 1990 |
The interaction of rat mutant allele lx with 5-azacytidine.
Topics: Abnormalities, Drug-Induced; Alleles; Animals; Azacitidine; Crosses, Genetic; Foot Deformities; Genotype; Mutation; Rats; Rats, Inbred BN; Rats, Inbred Lew; Recombination, Genetic; Syndrome | 1990 |